Burnout Syndrome (BOS) can be defined as a state of stress both physically and psychically due to the burden and stressor of high work. The prevalence of BOS in health workers varies between 25-75% globally. Studies have shown that the presence of Burnout syndrome will meaningfully reduce the quality of services related to patient safety and cause immune system disorders that act as the body's defense against viral, bacterial, protozoal and fungal infections. Many strategies have been researched to help prevent and reduce the occurrence of Burnout syndrome, one of which is music therapy. The purpose of this study was to determine the effect of music therapy on the immune response in health workers with Burnout Syndrome. This study is a randomized clinical trial with a pre and post test control group design for health workers at Dr Kariadi General Hospital and Dr. Cipto Mangunkusumo General Hospital. Subjects will be provided with information prior to the study and asked to sign an informed consent sheet if they agree to be involved in the study. Subjects will be divided into control groups and treatment groups with matching age, gender and type of work. In the treatment group, music therapy will be given as much as 3 times a week for 4 weeks. Data were taken on both groups before and after the intervention. This study used the Maslach Burnout Inventory Human Service Survey (MBI-HSS) and blood laboratory examination to determine the value of the Neutrophyl Lymphocyte Ratio, Interleukin 6 and Interleukin 10 levels.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Music therapy that have been made by Music Therapist after Focus Group discussion, given three times a week for 4 weeks
Cipto Mangunkusumo National Hospital
Jakarta, Indonesia
Burnout syndrome
Maslach Burnout Inventory Human Service Survey (MBI-HSS) score
Time frame: change from baseline score at 4 weeks
Neutrophil Lymphocyte Ratio
Measured with Fluorescence Flow Cytometry
Time frame: Change from baseline Neutrophil Lymphocyte Ratio at 4 weeks
Interleukin 6
Measured with Fluorescence Immunoassay
Time frame: Change from baseline Interleukin-6 level at 4 weeks
Interleukin 10
Measured with ELISA
Time frame: Change from baseline Interleukin-10 level at 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.